AR040301A1 - Composicion osmotica expansible y suspension para revestimiento mejoradas - Google Patents

Composicion osmotica expansible y suspension para revestimiento mejoradas

Info

Publication number
AR040301A1
AR040301A1 ARP030102341A ARP030102341A AR040301A1 AR 040301 A1 AR040301 A1 AR 040301A1 AR P030102341 A ARP030102341 A AR P030102341A AR P030102341 A ARP030102341 A AR P030102341A AR 040301 A1 AR040301 A1 AR 040301A1
Authority
AR
Argentina
Prior art keywords
weight
suspension
expansible
improved coating
osmotic composition
Prior art date
Application number
ARP030102341A
Other languages
English (en)
Spanish (es)
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of AR040301A1 publication Critical patent/AR040301A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Paper (AREA)
ARP030102341A 2002-06-28 2003-06-27 Composicion osmotica expansible y suspension para revestimiento mejoradas AR040301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39277502P 2002-06-28 2002-06-28

Publications (1)

Publication Number Publication Date
AR040301A1 true AR040301A1 (es) 2005-03-23

Family

ID=30000934

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030102341A AR040301A1 (es) 2002-06-28 2003-06-27 Composicion osmotica expansible y suspension para revestimiento mejoradas

Country Status (15)

Country Link
US (1) US7338663B2 (enExample)
EP (1) EP1528913A1 (enExample)
JP (1) JP2005532374A (enExample)
KR (1) KR20050071375A (enExample)
CN (1) CN1678292A (enExample)
AR (1) AR040301A1 (enExample)
AU (1) AU2003248868A1 (enExample)
CA (1) CA2490683A1 (enExample)
IL (1) IL165864A0 (enExample)
MX (1) MXPA05000207A (enExample)
NO (1) NO20050181L (enExample)
NZ (1) NZ537343A (enExample)
TW (1) TW200414900A (enExample)
WO (1) WO2004002450A1 (enExample)
ZA (1) ZA200500826B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US7241805B2 (en) 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
CA2655596C (en) * 2006-06-27 2011-10-25 Biovail Laboratories International Srl Multiparticulate osmotic delivery system
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
US7824557B2 (en) * 2007-08-08 2010-11-02 General Electric Company Method for controlling microbial biofilm in aqueous systems
US7785478B2 (en) * 2007-08-08 2010-08-31 General Electric Company Method for controlling protozoa that harbor bacteria
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
US20110052655A1 (en) * 2007-08-08 2011-03-03 Wilson Kurt Whitekettle Methods and vesicles for controlling protozoa
CN102871982B (zh) 2012-10-16 2014-09-10 中国科学院上海药物研究所 一种药物渗透泵制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US36472A (en) * 1862-09-16 Cttlvebt
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5800422A (en) * 1995-06-02 1998-09-01 Alza Corporation Osmotic device with delayed activation of drug delivery and complete drug release
DE69915346T2 (de) * 1998-12-17 2004-07-22 Alza Corp., Mountain View Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system

Also Published As

Publication number Publication date
TW200414900A (enExample) 2004-08-16
EP1528913A1 (en) 2005-05-11
MXPA05000207A (es) 2005-06-06
US7338663B2 (en) 2008-03-04
NZ537343A (en) 2007-06-29
CN1678292A (zh) 2005-10-05
JP2005532374A (ja) 2005-10-27
KR20050071375A (ko) 2005-07-07
WO2004002450A1 (en) 2004-01-08
AU2003248868A1 (en) 2004-01-19
NO20050181L (no) 2005-01-12
CA2490683A1 (en) 2004-01-08
US20040058002A1 (en) 2004-03-25
ZA200500826B (en) 2006-08-30
IL165864A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
AR029737A1 (es) Concentrados de anticongelantes a base de amidas y composiciones refrigerantes que los comprenden, para la proteccion del magnesio y aleaciones de magnesio
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
AR015900A1 (es) Una formulacion farmaceutica que comprende voriconazol o un derivado farmaceuticamente aceptable del mismo y un derivado de ciclodextrina.
BR0116217A (pt) Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
ES2153927T3 (es) Intermedios de dioxolano.
PE20011122A1 (es) DERIVADOS DE PURINA-2-ILCARBOXAMIDA COMO AGONISTAS SELECTIVOS DEL RECEPTOR A2a DE LA ADENOSINA
CR7952A (es) Sistema terapeutico transdermico estable a los rayos uv
AR038379A1 (es) Esteres de acidos fluoreno-carboxilicos, procedimientos para su preparacion asi como su utilizacion en calidad de medicamentos
CO5231147A1 (es) Composicion congelante
CO6382164A2 (es) Solucion acuosa para la preservacion de tejidos y organos
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
AR031649A1 (es) Composicion farmaceutica de dronedarona para administracion parenteral
AR047279A1 (es) Composicion detergente liquida
EP4015042A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTIFUNGAL AS AN ACTIVE SUBSTANCE
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
ES2093682T3 (es) Composiciones de isotiazolona diluibles en agua.
GT200100218A (es) Compuesto agroquimico.
ES2063412T3 (es) Tableta y granulado que contienen como principio activo mesna.
AR032455A1 (es) Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
ES2106696T1 (es) Un comprimido de ranitidina que tiene un revestimiento que contiene hidroxipropilmetilcelulosa y un metodo para producir dicho revestimiento.
CO4750591A1 (es) Procedimiento de lucha contra los insectos
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal